KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organon (OGN) Depreciation and Depletion (2020 - 2025)

Historic Depreciation and Depletion for Organon (OGN) over the last 6 years, with Q3 2025 value amounting to $40.0 million.

  • Organon's Depreciation and Depletion rose 1764.71% to $40.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $144.0 million, marking a year-over-year increase of 1076.92%. This contributed to the annual value of $132.0 million for FY2024, which is 1000.0% up from last year.
  • Per Organon's latest filing, its Depreciation and Depletion stood at $40.0 million for Q3 2025, which was up 1764.71% from $36.0 million recorded in Q2 2025.
  • In the past 5 years, Organon's Depreciation and Depletion ranged from a high of $40.0 million in Q3 2025 and a low of $18.0 million during Q1 2021
  • Its 5-year average for Depreciation and Depletion is $28.9 million, with a median of $28.0 million in 2021.
  • Per our database at Business Quant, Organon's Depreciation and Depletion skyrocketed by 10000.0% in 2021 and then tumbled by 1428.57% in 2022.
  • Over the past 5 years, Organon's Depreciation and Depletion (Quarter) stood at $28.0 million in 2021, then dropped by 14.29% to $24.0 million in 2022, then skyrocketed by 33.33% to $32.0 million in 2023, then increased by 6.25% to $34.0 million in 2024, then increased by 17.65% to $40.0 million in 2025.
  • Its Depreciation and Depletion was $40.0 million in Q3 2025, compared to $36.0 million in Q2 2025 and $34.0 million in Q1 2025.